Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Arl6ip5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ARL6IP5 mRNA | CTD | PMID:22206623 | Arl6ip5 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL6IP5 mRNA | CTD | PMID:22206623 | Arl6ip5 | Rat | 17beta-estradiol | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Estradiol affects the expression of ARL6IP5 mRNA | CTD | PMID:14699072 | Arl6ip5 | Rat | 17beta-estradiol | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ARL6IP5 mRNA | CTD | PMID:23019147 | Arl6ip5 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | Arl6ip5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARL6IP5 mRNA | CTD | PMID:21570461 | Arl6ip5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARL6IP5 mRNA | CTD | PMID:33387578 | Arl6ip5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ARL6IP5 mRNA | CTD | PMID:34747641 | Arl6ip5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ARL6IP5 mRNA | CTD | PMID:15034205 more ... | Arl6ip5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ARL6IP5 mRNA | CTD | PMID:25975270 | Arl6ip5 | Rat | 2-hydroxypropanoic acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of ARL6IP5 mRNA | CTD | PMID:30851411 | Arl6ip5 | Rat | 2-methylcholine | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of ARL6IP5 mRNA | CTD | PMID:21179406 | Arl6ip5 | Rat | 3-methylcholanthrene | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of ARL6IP5 mRNA | CTD | PMID:20713471 | Arl6ip5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of ARL6IP5 protein | CTD | PMID:34186270 | Arl6ip5 | Rat | 4-hydroxyphenyl retinamide | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Fenretinide affects the expression of ARL6IP5 | CTD | PMID:16720286 | Arl6ip5 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Decitabine affects the expression of ARL6IP5 mRNA | CTD | PMID:23300844 | Arl6ip5 | Rat | 5-fluorouracil | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] and ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] | CTD | PMID:22452940 | Arl6ip5 | Rat | 5-formyltetrahydrofolic acid | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] and ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] | CTD | PMID:22452940 | Arl6ip5 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ARL6IP5 mRNA | CTD | PMID:24780913 | Arl6ip5 | Rat | 7,12-dimethyltetraphene | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | [9 more ... | CTD | PMID:32553695 | Arl6ip5 | Rat | 7,12-dimethyltetraphene | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | Arl6ip5 | Rat | acetylsalicylic acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Aspirin results in increased expression of ARL6IP5 mRNA | CTD | PMID:15928584 | Arl6ip5 | Rat | all-trans-retinoic acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ARL6IP5 mRNA and Tretinoin results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 more ... | Arl6ip5 | Rat | all-trans-retinoic acid | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Tretinoin affects the expression of ARL6IP5 | CTD | PMID:16720286 | Arl6ip5 | Rat | all-trans-retinoic acid | increases response to substance | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein results in increased susceptibility to Tretinoin | CTD | PMID:16922813 | Arl6ip5 | Rat | all-trans-retinoic acid | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ARL6IP5 mRNA more ... | CTD | PMID:16468075 and PMID:16922813 | Arl6ip5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ARL6IP5 mRNA | CTD | PMID:16483693 | Arl6ip5 | Rat | Aroclor 1254 | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of ARL6IP5 mRNA | CTD | PMID:25270620 | Arl6ip5 | Rat | arsenite(3-) | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | arsenite results in increased expression of ARL6IP5 mRNA | CTD | PMID:15894712 | Arl6ip5 | Rat | arsenite(3-) | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA | CTD | PMID:15894712 | Arl6ip5 | Rat | arsenous acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 | Arl6ip5 | Rat | arsenous acid | increases response to substance | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide | CTD | PMID:18387645 | Arl6ip5 | Rat | arsenous acid | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein more ... | CTD | PMID:16468075 and PMID:18387645 | Arl6ip5 | Rat | benzene-1,2,4-triol | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | hydroxyhydroquinone results in decreased expression of ARL6IP5 mRNA | CTD | PMID:17572062 | Arl6ip5 | Rat | benzo[a]pyrene | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA and [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA | CTD | PMID:15894712 and PMID:32553695 | Arl6ip5 | Rat | benzo[a]pyrene | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in increased expression of ARL6IP5 mRNA and Benzo(a)pyrene results in increased expression of ARL6IP5 mRNA | CTD | PMID:15034205 more ... | Arl6ip5 | Rat | bexarotene | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | bexarotene results in increased expression of ARL6IP5 mRNA | CTD | PMID:17178900 | Arl6ip5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ARL6IP5 mRNA | CTD | PMID:25181051 | Arl6ip5 | Rat | bisphenol A | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ARL6IP5 protein | CTD | PMID:37664457 | Arl6ip5 | Rat | bisphenol A | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ARL6IP5 protein | CTD | PMID:33376534 more ... | Arl6ip5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ARL6IP5 mRNA | CTD | PMID:30816183 and PMID:32528016 | Arl6ip5 | Rat | Bisphenol B | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of ARL6IP5 protein | CTD | PMID:34186270 | Arl6ip5 | Rat | bisphenol F | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of ARL6IP5 protein | CTD | PMID:34186270 | Arl6ip5 | Rat | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of ARL6IP5 protein | CTD | PMID:28903499 | Arl6ip5 | Rat | carbon nanotube | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | Arl6ip5 | Rat | chloropicrin | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of ARL6IP5 mRNA | CTD | PMID:26352163 | Arl6ip5 | Rat | chromium(6+) | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ARL6IP5 mRNA | CTD | PMID:38479592 | Arl6ip5 | Rat | cisplatin | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Cisplatin affects the expression of ARL6IP5 mRNA | CTD | PMID:23300844 | Arl6ip5 | Rat | cisplatin | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] | CTD | PMID:22452940 | Arl6ip5 | Rat | clofibrate | decreases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of ARL6IP5 mRNA | CTD | PMID:17585979 | Arl6ip5 | Rat | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ARL6IP5 mRNA | CTD | PMID:30556269 | Arl6ip5 | Rat | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ARL6IP5 mRNA | CTD | PMID:30556269 | Arl6ip5 | Rat | copper(II) sulfate | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ARL6IP5 mRNA | CTD | PMID:19549813 | Arl6ip5 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of ARL6IP5 mRNA | CTD | PMID:26577399 | Arl6ip5 | Rat | cyclosporin A | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ARL6IP5 mRNA | CTD | PMID:20106945 and PMID:25562108 | Arl6ip5 | Rat | cytarabine | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Cytarabine results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 | Arl6ip5 | Rat | diarsenic trioxide | increases response to substance | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide | CTD | PMID:18387645 | Arl6ip5 | Rat | diarsenic trioxide | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 | Arl6ip5 | Rat | diarsenic trioxide | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein more ... | CTD | PMID:16468075 and PMID:18387645 | Arl6ip5 | Rat | Dibutyl phosphate | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ARL6IP5 mRNA | CTD | PMID:37042841 | Arl6ip5 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ARL6IP5 mRNA | CTD | PMID:21266533 | Arl6ip5 | Rat | dicrotophos | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ARL6IP5 mRNA | CTD | PMID:28302478 | Arl6ip5 | Rat | diuron | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Diuron results in decreased expression of ARL6IP5 mRNA | CTD | PMID:35967413 | Arl6ip5 | Rat | doxorubicin | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 | Arl6ip5 | Rat | etoposide | increases response to substance | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein results in increased susceptibility to Etoposide | CTD | PMID:19492242 | Arl6ip5 | Rat | etoposide | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Etoposide results in decreased expression of ARL6IP5 | CTD | PMID:19492242 | Arl6ip5 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of ARL6IP5 mRNA | CTD | PMID:31881178 | Arl6ip5 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ARL6IP5 mRNA | CTD | PMID:24136188 | Arl6ip5 | Rat | folic acid | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL6IP5 mRNA | CTD | PMID:22206623 | Arl6ip5 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ARL6IP5 mRNA | CTD | PMID:22061828 and PMID:33387578 | Arl6ip5 | Rat | hemin | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Hemin results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 | Arl6ip5 | Rat | hydralazine | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA | CTD | PMID:17183730 | Arl6ip5 | Rat | hydrogen peroxide | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein and CAT protein inhibits the reaction [[arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein] | CTD | PMID:18387645 | Arl6ip5 | Rat | ivermectin | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ARL6IP5 protein | CTD | PMID:32959892 | Arl6ip5 | Rat | kojic acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | kojic acid results in increased expression of ARL6IP5 mRNA | CTD | PMID:16595896 | Arl6ip5 | Rat | Mesaconitine | decreases expression | EXP | | 6480464 | mesaconitine results in decreased expression of ARL6IP5 protein | CTD | PMID:37182599 | Arl6ip5 | Rat | methylmercury chloride | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ARL6IP5 mRNA | CTD | PMID:23179753 | Arl6ip5 | Rat | morphine | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein] more ... | CTD | PMID:21600884 | Arl6ip5 | Rat | morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of ARL6IP5 protein | CTD | PMID:21600884 | Arl6ip5 | Rat | morphine | multiple interactions | EXP | | 6480464 | ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein] more ... | CTD | PMID:21600884 | Arl6ip5 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein]] | CTD | PMID:21600884 | Arl6ip5 | Rat | nickel subsulfide | increases expression | EXP | | 6480464 | nickel subsulfide results in increased expression of ARL6IP5 mRNA | CTD | PMID:21086188 | Arl6ip5 | Rat | oxaliplatin | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] | CTD | PMID:22452940 | Arl6ip5 | Rat | ozone | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ARL6IP5 mRNA | CTD | PMID:35430440 | Arl6ip5 | Rat | paracetamol | affects expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ARL6IP5 mRNA | CTD | PMID:17562736 | Arl6ip5 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ARL6IP5 mRNA | CTD | PMID:33387578 | Arl6ip5 | Rat | paracetamol | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ARL6IP5 mRNA | CTD | PMID:21420995 and PMID:29067470 | Arl6ip5 | Rat | paraquat | affects response to substance | ISO | Arl6ip5 (Mus musculus) | 6480464 | ARL6IP5 protein affects the susceptibility to Paraquat | CTD | PMID:28428137 | Arl6ip5 | Rat | paraquat | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Paraquat results in increased expression of ARL6IP5 | CTD | PMID:28428137 | Arl6ip5 | Rat | paraquat | multiple interactions | ISO | Arl6ip5 (Mus musculus) | 6480464 | ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] more ... | CTD | PMID:28428137 | Arl6ip5 | Rat | paraquat | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Paraquat results in increased expression of ARL6IP5 protein | CTD | PMID:28428137 | Arl6ip5 | Rat | paraquat | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] more ... | CTD | PMID:28428137 | Arl6ip5 | Rat | parathion | decreases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Parathion results in decreased expression of ARL6IP5 mRNA | CTD | PMID:34813904 | Arl6ip5 | Rat | perfluorooctanoic acid | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of ARL6IP5 protein | CTD | PMID:26879310 | Arl6ip5 | Rat | phenobarbital | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of ARL6IP5 mRNA | CTD | PMID:19270015 | Arl6ip5 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [Tretinoin results in increased expression of ARL6IP5 mRNA] | CTD | PMID:16468075 | Arl6ip5 | Rat | phorbol 13-acetate 12-myristate | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of ARL6IP5 protein | CTD | PMID:16430862 | Arl6ip5 | Rat | phoxim | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | phoxim affects the expression of ARL6IP5 protein | CTD | PMID:15799245 | Arl6ip5 | Rat | piroxicam | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Piroxicam results in increased expression of ARL6IP5 mRNA | CTD | PMID:21858171 | Arl6ip5 | Rat | potassium chromate | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ARL6IP5 mRNA | CTD | PMID:22714537 | Arl6ip5 | Rat | quercetin | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ARL6IP5 mRNA | CTD | PMID:21632981 | Arl6ip5 | Rat | rac-lactic acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of ARL6IP5 mRNA | CTD | PMID:30851411 | Arl6ip5 | Rat | rotenone | decreases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Rotenone results in decreased expression of ARL6IP5 mRNA | CTD | PMID:23186747 | Arl6ip5 | Rat | SB 431542 | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ARL6IP5 protein | CTD | PMID:37664457 | Arl6ip5 | Rat | temozolomide | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of ARL6IP5 mRNA | CTD | PMID:31758290 | Arl6ip5 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA | CTD | PMID:15336504 | Arl6ip5 | Rat | tetrachloromethane | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ARL6IP5 mRNA | CTD | PMID:27339419 and PMID:31919559 | Arl6ip5 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ARL6IP5 mRNA | CTD | PMID:34492290 | Arl6ip5 | Rat | thiram | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Thiram results in decreased expression of ARL6IP5 mRNA | CTD | PMID:38568856 | Arl6ip5 | Rat | triphenyl phosphate | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ARL6IP5 mRNA | CTD | PMID:37042841 | Arl6ip5 | Rat | trovafloxacin | increases expression | ISO | Arl6ip5 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of ARL6IP5 mRNA | CTD | PMID:35537566 | Arl6ip5 | Rat | valproic acid | multiple interactions | ISO | ARL6IP5 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA | CTD | PMID:17183730 | Arl6ip5 | Rat | valproic acid | increases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ARL6IP5 mRNA | CTD | PMID:19101580 more ... | Arl6ip5 | Rat | valproic acid | affects expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ARL6IP5 mRNA | CTD | PMID:25979313 | Arl6ip5 | Rat | zinc atom | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of ARL6IP5 mRNA | CTD | PMID:22171008 | Arl6ip5 | Rat | zinc(0) | decreases expression | ISO | ARL6IP5 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of ARL6IP5 mRNA | CTD | PMID:22171008 | |